Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 1
1962 1
1963 2
1966 2
1967 4
1968 4
1969 9
1970 6
1971 15
1972 14
1973 14
1974 24
1975 33
1976 24
1977 25
1978 18
1979 27
1980 22
1981 23
1982 28
1983 45
1984 56
1985 52
1986 36
1987 42
1988 46
1989 51
1990 70
1991 59
1992 81
1993 109
1994 131
1995 110
1996 103
1997 161
1998 130
1999 160
2000 150
2001 128
2002 134
2003 147
2004 192
2005 181
2006 207
2007 257
2008 233
2009 247
2010 332
2011 315
2012 301
2013 381
2014 404
2015 378
2016 395
2017 399
2018 475
2019 488
2020 526
2021 540
2022 405
2023 380
2024 129

Text availability

Article attribute

Article type

Publication date

Search Results

8,267 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Peripheral nervous system cancer"
Page 1
Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer.
Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS. Bakst RL, et al. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1109-1124. doi: 10.1016/j.ijrobp.2018.12.009. Epub 2018 Dec 15. Int J Radiat Oncol Biol Phys. 2019. PMID: 30562546 Review.
Perineural invasion (PNI), the neoplastic invasion of nerves, is a common pathologic finding in head and neck cancer that is associated with poor clinical outcomes. PNI is a histologic finding of tumor cell infiltration and is distinct from perineural tumor spread (PNTS), …
Perineural invasion (PNI), the neoplastic invasion of nerves, is a common pathologic finding in head and neck cancer that is associat …
Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM, Rodriguez FJ. Belakhoua SM, et al. Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021. Neurosurgery. 2021. PMID: 33588442 Free PMC article. Review.
Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. ...We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial sy …
Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological …
A contouring guide for head and neck cancers with perineural invasion.
Ko HC, Gupta V, Mourad WF, Hu KS, Harrison LB, Som PM, Bakst RL. Ko HC, et al. Pract Radiat Oncol. 2014 Nov-Dec;4(6):e247-58. doi: 10.1016/j.prro.2014.02.001. Epub 2014 Mar 26. Pract Radiat Oncol. 2014. PMID: 25407876
PURPOSE: Perineural invasion (PNI) is a frequent pathological finding in head and neck cancers. When adjuvant radiation to cranial nerves at risk in head and neck cancers with PNI is considered, there is a need for consensus on which nerves are at risk and how to co …
PURPOSE: Perineural invasion (PNI) is a frequent pathological finding in head and neck cancers. When adjuvant radiation to cranial ne …
Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy.
Best RL, LaPointe NE, Azarenko O, Miller H, Genualdi C, Chih S, Shen BQ, Jordan MA, Wilson L, Feinstein SC, Stagg NJ. Best RL, et al. Toxicol Appl Pharmacol. 2021 Jun 15;421:115534. doi: 10.1016/j.taap.2021.115534. Epub 2021 Apr 20. Toxicol Appl Pharmacol. 2021. PMID: 33852878
Monomethyl auristatin E (MMAE) is a potent anti-cancer microtubule-targeting agent (MTA) used as a payload in three approved MMAE-containing antibody drug conjugates (ADCs) and multiple ADCs in clinical development to treat different types of cancers. ...MMAE-ADC-in …
Monomethyl auristatin E (MMAE) is a potent anti-cancer microtubule-targeting agent (MTA) used as a payload in three approved MMAE-con …
Immune-mediated diseases involving central and peripheral nervous systems.
Leboyan A, Esselin F, Bascou AL, Duflos C, Ion I, Charif M, Castelnovo G, Carra-Dalliere C, Ayrignac X, Kerschen P, Chbicheb M, Nguyen L, Maria ATJ, Guilpain P, Carriere M, de Champfleur NM, Vincent T, Jentzer A, Labauge P, Devaux JJ, Taieb G. Leboyan A, et al. Eur J Neurol. 2023 Feb;30(2):490-500. doi: 10.1111/ene.15628. Epub 2022 Nov 27. Eur J Neurol. 2023. PMID: 36366904
BACKGROUND AND PURPOSE: In addition to combined central and peripheral demyelination, other immune diseases could involve both the central nervous system (CNS) and peripheral nervous system (PNS). METHODS: To identify immune-mediated dise …
BACKGROUND AND PURPOSE: In addition to combined central and peripheral demyelination, other immune diseases could involve both the ce …
Peripheral nervous system adverse events associated with immune checkpoint inhibitors.
Rossi S, Gelsomino F, Rinaldi R, Muccioli L, Comito F, Di Federico A, De Giglio A, Lamberti G, Andrini E, Mollica V, D'Angelo R, Baccari F, Zenesini C, Madia P, Raschi E, Cortelli P, Ardizzoni A, Guarino M. Rossi S, et al. J Neurol. 2023 Jun;270(6):2975-2986. doi: 10.1007/s00415-023-11625-1. Epub 2023 Feb 17. J Neurol. 2023. PMID: 36800019 Free PMC article.
The aim of this study was to characterize irAEs involving the peripheral nervous system (PNS-irAEs) in a real-world cohort of ICI-treated patients. METHODS: Cancer patients treated with ICIs between January 2014 and March 2022 were included. ...
The aim of this study was to characterize irAEs involving the peripheral nervous system (PNS-irAEs) in a real-world coh …
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.
Staedtke V, Bai RY, Blakeley JO. Staedtke V, et al. Neurotherapeutics. 2017 Apr;14(2):298-306. doi: 10.1007/s13311-017-0518-y. Neurotherapeutics. 2017. PMID: 28349408 Free PMC article. Review.
The RASopathy neurofibromatosis 1 is an autosomal dominant hereditary cancer syndrome that represents a major risk for the development of malignancies, particularly malignant peripheral nerve sheath tumors (MPNSTs). MPNSTs are unique sarcomas that originate from the …
The RASopathy neurofibromatosis 1 is an autosomal dominant hereditary cancer syndrome that represents a major risk for the developmen …
Hearing and Other Neurologic Problems.
Landier W, Cohn RJ, van den Heuvel-Eibrink MM. Landier W, et al. Pediatr Clin North Am. 2020 Dec;67(6):1219-1235. doi: 10.1016/j.pcl.2020.07.012. Epub 2020 Sep 23. Pediatr Clin North Am. 2020. PMID: 33131543 Review.
Ototoxicity and other neurologic toxicities are potential consequences of exposure to common therapeutic agents used during treatment of childhood cancer, including platinum and vinca alkaloid chemotherapy, cranial radiation, surgery involving structures critical to cochle …
Ototoxicity and other neurologic toxicities are potential consequences of exposure to common therapeutic agents used during treatment of chi …
Chemotherapy-induced peripheral neuropathy.
Visovsky C. Visovsky C. Cancer Invest. 2003 Jun;21(3):439-51. doi: 10.1081/cnv-120018236. Cancer Invest. 2003. PMID: 12901290 Review.
Although the use of chemotherapeutic agents can serve to prolong life, such agents are associated with significant side effects. Increasing clinical evidence suggests treatment of cancer with neurotoxic agents results in some degree of peripheral neuropathy. ...As s …
Although the use of chemotherapeutic agents can serve to prolong life, such agents are associated with significant side effects. Increasing …
DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions.
Englander EW. Englander EW. DNA Repair (Amst). 2013 Aug;12(8):685-90. doi: 10.1016/j.dnarep.2013.04.020. Epub 2013 May 16. DNA Repair (Amst). 2013. PMID: 23684797 Free PMC article. Review.
In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader spectrum of endogenous and exogenous threats compared to that of the central nervous system (CNS). ...Here, I review data show …
In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader …
8,267 results